🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.

Platform Reaction and Material Removal

According to the social media company, the service has removed violative material and prohibited related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of weight loss, glowing testimonials and detailed guides for mixing or administering at home.

Within moments of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, posts show dark colored packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to potentially serious medical dangers”.